Senior Finance Analyst – AGP Governance

Synthes GmbH

Bewerben
  • Veröffentlicht:

    06 Mai 2024
  • Pensum:

    100%
  • Vertrag:

    Festanstellung
  • Arbeitsort:

    Zuchwil

Senior Finance Analyst – AGP Governance

Senior Finance Analyst – AGP Governance

Location: Cork, Ireland/Guaynabo, Puerto Rico/Zuchwil or Zug, Switzerland

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/ .

With $83 billion in 2020 sales, Johnson & Johnson is the world's most comprehensive and broadly-based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices markets. There are more than 250 Johnson & Johnson operating companies employing over 125,000 people and with products touching the lives of over a billion people every day, throughout the world. If you have the talent and desire to touch the world, Johnson & Johnson has the career opportunities to help make it happen.

This role will report to the Senior Finance Analyst (Team Lead), AGP Governance part of the Medical Devices (MD) Principal Costing CoE.

This is a fixed-term contract for 23 months.



  • Responsibilities and scope of the role include, but are not limited to, the following:




  • Maintenance of the MD Supply Chain Affiliate Gross Profit (AGP) Tool and related master data. The AGP Tool is a Tableau front ended technology which consolidated MD inventory and commercial sales from ~ 20 individual ERPs into one application




  •  Governance, calculation and reporting of the MD Supply Chain Profit in Inventory Reserve for selected franchises (total MD SC PII for all franchises ~ USD 3.5 Billion reserve)




  • Performing SOX compliance controls for the AGP Tool including key controls around Supply Chain Master Data, including evaluating potential ways to streamline the SOX 404 compliance controls for the AGP tool ensuring no risk to compliance, and secure alignment from Internal and External Audit




  • Partnering with key stakeholder groups (Business Unit Finance, Intercompany Pricing, JJIT, ERP rollout and SigniFi teams) to shape the future end state for the AGP Tool and the calculation of the MD Supply Chain Profit in Inventory reserve 




  • Supporting PIC COE projects in collaboration with key stakeholders (Business Unit Finance, Intercompany Pricing and JJIT)




Kontakt

  • Synthes GmbH

Bewerben